Safety and Tolerability of Artificial Tears in Dry Eye Subjects

• Status: Completed
• Trial end date: 2009-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The safety and tolerability of two new artificial tears will be compared to a currently-available artificial tear in subjects with dry eye. Each subject will receive all three products in a randomly assigned order. The subject will use one product at a time for a duration of one week before switching to the next assigned product.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Carboxymethylcellulose Sodium; Glycerol; Lubricant Eye Drops

Criteria

Inclusion Criteria:

• Mild, moderate or severe symptoms of dry eye

Exclusion Criteria:

• Uncontrolled systemic disease

• Contact lens wear

• Participation in another clinical study